Seth B. Cohen Sells 23,908 Shares of Castlight Health Inc (NYSE:CSLT) Stock

Castlight Health Inc (NYSE:CSLT) Director Seth B. Cohen sold 23,908 shares of the company’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $1.19, for a total value of $28,450.52. Following the completion of the sale, the director now directly owns 441,492 shares of the company’s stock, valued at $525,375.48. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of CSLT stock opened at $1.17 on Wednesday. The stock has a 50 day simple moving average of $1.19 and a 200-day simple moving average of $0.90. Castlight Health Inc has a 12-month low of $0.60 and a 12-month high of $1.79.

Castlight Health (NYSE:CSLT) last released its quarterly earnings data on Tuesday, July 28th. The software maker reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.06. Castlight Health had a negative return on equity of 16.36% and a negative net margin of 55.73%. The firm had revenue of $35.50 million during the quarter, compared to the consensus estimate of $30.40 million. On average, equities research analysts expect that Castlight Health Inc will post -0.21 earnings per share for the current year.

CSLT has been the subject of a number of research analyst reports. Canaccord Genuity reissued a “hold” rating and issued a $1.00 target price on shares of Castlight Health in a research report on Wednesday, July 29th. Zacks Investment Research cut Castlight Health from a “buy” rating to a “hold” rating in a research report on Monday, June 22nd. Finally, Wells Fargo & Company decreased their target price on Castlight Health from $1.15 to $0.75 and set an “underweight” rating for the company in a research report on Tuesday, May 19th. One investment analyst has rated the stock with a sell rating and four have issued a hold rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $1.19.

A number of institutional investors have recently added to or reduced their stakes in CSLT. Metropolitan Life Insurance Co NY purchased a new position in Castlight Health during the first quarter worth $97,000. SG Americas Securities LLC increased its position in Castlight Health by 197.0% during the first quarter. SG Americas Securities LLC now owns 39,880 shares of the software maker’s stock worth $29,000 after buying an additional 26,453 shares in the last quarter. Acadian Asset Management LLC increased its position in Castlight Health by 46.0% during the first quarter. Acadian Asset Management LLC now owns 1,115,071 shares of the software maker’s stock worth $806,000 after buying an additional 351,190 shares in the last quarter. Gagnon Advisors LLC increased its position in Castlight Health by 33.0% during the first quarter. Gagnon Advisors LLC now owns 2,540,341 shares of the software maker’s stock worth $1,837,000 after buying an additional 630,516 shares in the last quarter. Finally, Gagnon Securities LLC increased its position in Castlight Health by 40.1% during the first quarter. Gagnon Securities LLC now owns 4,071,654 shares of the software maker’s stock worth $2,944,000 after buying an additional 1,164,486 shares in the last quarter. 60.77% of the stock is owned by institutional investors.

About Castlight Health

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.

Recommended Story: Forex

Insider Buying and Selling by Quarter for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.